Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. TWST
TWST logo

TWST

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TWST News

Twist Bioscience Launches Complex Genes Product Line

May 23 2026Yahoo Finance

TWIST BIOSCIENCE CORP: TD COWEN INCREASES TARGET PRICE FROM $58 TO $68

May 05 2026moomoo

Twist Bioscience Reports Strong Q2 Earnings with AI Growth

May 04 2026seekingalpha

Twist Bioscience Q2 Earnings Beat Expectations with Revenue Growth

May 04 2026seekingalpha

Twist Bioscience Launches Complex Gene Synthesis Service

May 04 2026Newsfilter

Twist Bioscience Q2 Earnings Announcement Scheduled

May 01 2026seekingalpha

Market Overview: Investment Opportunities and Risks

Mar 01 2026Benzinga

ARK Invest's 2025 Performance Review Highlights Key Stocks

Feb 24 2026Benzinga

Twist Bioscience Executive Stock Sale Affects Market Sentiment

Feb 20 2026seekingalpha

Twist Bioscience Acquires Antibody Platform Rights from Invenra

Feb 17 2026seekingalpha

Biotech Sector Faces FDA Turmoil

Feb 11 2026Fool

Twist Bioscience Reports Strong Q1 Sales, Raises Guidance

Feb 03 2026Benzinga

Twist Bioscience Reports Q1 2026 Results with Revenue Growth and Improved Margins

Feb 02 2026Benzinga

Twist Bioscience Reports Strong Q1 2026 Earnings with Revenue Growth

Feb 02 2026seekingalpha

Twist Bioscience Raises FY 2026 Revenue Guidance

Feb 02 2026stocktwits

Twist Bioscience Reports Improved Q1 Losses, Shares Rise

Feb 02 2026NASDAQ.COM